Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jae ParkSusan K Seo

Abstract

Chimeric antigen receptor (CAR)-modified T cells that target the CD19 antigen present a novel promising therapy for the treatment of relapsed B-cell acute lymphoblastic leukemia (B-ALL). Although cytokine release syndrome (CRS) and neurotoxicity have emerged as predominant noninfectious complications of CD19 CAR T-cell therapy, infections associated with this treatment modality have not been well documented. We analyzed infectious complications that followed CD19 CAR T-cell therapy in 53 adult patients with relapsed B-ALL enrolled in a phase I clinical trial at Memorial Sloan Kettering Cancer Center (NCT01044069). Overall, 22 patients (42%) experienced 26 infections (17 bacterial, 4 fungal, and 5 viral) within the first 30 days of CAR T-cell infusion. In 10 of 32 (31%) patients in whom complete remission was achieved, 15 infections developed between days 31 and 180; the majority of these late infections were due to respiratory viruses. In general, bacterial, fungal, and viral infections were detected at a median of 18, 23, and 48 days, respectively, after CAR T-cell infusion. CRS grade 3 or higher was independently associated with increased risk of subsequent infection (adjusted hazard ratio [HR], 2.67; P = .05) and in particul...Continue Reading

References

Oct 15, 2005·Clinical Microbiology Reviews·Conan MacDougall, Ron E Polk
Oct 13, 2006·Blood·Adele K FieldingUNKNOWN Eastern Cooperative Oncology Group
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Dec 26, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinJohn G Bartlett
Mar 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stuart H CohenUNKNOWN Infectious Diseases Society of America
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Feb 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kalpana GuptaUNKNOWN European Society for Microbiology and Infectious Diseases
Oct 2, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hans H HirschPer Ljungman
Apr 25, 2013·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Hamid MoradiKamyar Kalantar-Zadeh
Dec 7, 2013·International Journal of Hematology·Marco L DavilaRenier Brentjens
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Jun 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensJames C Wade
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Apr 26, 2016·The Journal of Clinical Investigation·Cameron J TurtleDavid G Maloney
May 22, 2016·Blood·Jennifer N Brudno, James N Kochenderfer
Jul 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andre C KalilJan L Brozek
Sep 15, 2016·Molecular Therapy Oncolytics·Challice L BonifantKevin J Curran
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Sep 20, 2017·Nature Reviews. Clinical Oncology·Sattva S NeelapuElizabeth J Shpall

❮ Previous
Next ❯

Citations

Feb 21, 2019·American Journal of Hematology·Alexandre V Hirayama, Cameron J Turtle
Dec 7, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jay A FishmanMarcela V Maus
Nov 26, 2019·Current Opinion in Hematology·Rosalie M Sterner, Saad S Kenderian
Oct 24, 2019·Journal for Immunotherapy of Cancer·Hui LuoJianfeng Zhou
Feb 19, 2020·Expert Opinion on Biological Therapy·Cassie K Chou, Cameron J Turtle
Nov 23, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ghady HaidarPalash Samanta
Nov 15, 2019·Clinical Microbiology Reviews·Jean-Paul Latgé, Georgios Chamilos
Aug 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Jan 12, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ghady HaidarPalash Samanta
Feb 23, 2020·Frontiers in Oncology·Monica S ThakarSubramaniam Malarkannan
Jul 14, 2020·Current Opinion in Infectious Diseases·Marcela V Maus, Michail S Lionakis
Aug 12, 2020·Archives of Virology·Saba ShamimGhulam Murtaza
Nov 7, 2019·Current Opinion in Infectious Diseases·Julian LindsayMonica Slavin
Jul 25, 2020·Intensive Care Medicine·Elie AzoulaySandrine Valade
Aug 8, 2020·Blood Cancer Journal·Kitsada WudhikarnMiguel-Angel Perales
Jul 31, 2020·Signal Transduction and Targeted Therapy·Jianshu WeiWeidong Han
Jun 2, 2018·Pharmaceutical Research·Paula SalmikangasPaul Chamberlain
May 26, 2018·Current Treatment Options in Oncology·Melody R Becnel, Loretta J Nastoupil
Feb 6, 2020·Therapeutic Advances in Hematology·Tania Jain, Mark R Litzow
Apr 15, 2020·Open Forum Infectious Diseases·Erin K McCreary, Jason M Pogue
Dec 1, 2020·Expert Review of Anti-infective Therapy·Olivia Bupha-IntrBenjamin Teh
Jan 13, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick M Reagan, Sattva S Neelapu
Jan 27, 2021·Nature Reviews. Clinical Oncology·Haneen ShalabiNirali N Shah
Nov 2, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark B LeickMatthew J Frigault
Feb 11, 2021·Leukemia & Lymphoma·Talya Wittmann DayagiAbraham Avigdor
Jan 4, 2021·Critical Reviews in Oncology/hematology·Alessandro BuscaUNKNOWN SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie)
Jan 28, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Mar 7, 2021·Cancers·Prathyaya RameshI Caroline Le Poole
Oct 26, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M-L SchubertP Dreger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.